Seminars in Nephrology
Volume 25, Issue 1 , Pages 25-31 , January 2005

Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: A statistical modeling perspective

  • Robert A. Short

      Affiliations

    • Research Department, The Heart Institute of Spokane, Spokane, WA.
    • Corresponding Author InformationAddress reprint requests to Robert A. Short, PhD, The Heart Institute of Spokane, 122 W. 7th Ave, Suite 230, Spokane, WA 99204-2340.
    • ,
  • Katherine R. Tuttle

      Affiliations

    • Research Department, The Heart Institute of Spokane, Spokane, WA.

References 

  1. Freedman DS , Williamson DF , Gunter EW , et al.   Relation of serum uric acid to mortality and ischemic heart disease (The NHANES I epidemiologic follow-up study) . Am J Epidemiol . 1995;141:637–644
  2. Kannel WB . Metabolic risk factors for coronary heart disease in women (Perspective from the Framingham Study) . Am Heart J . 1987;114:413–418
  3. Levine W , Dyer AR , Shekelle RB , et al.   Serum uric acid and 11.5-year mortality of middle-aged women (Findings of the Chicago Heart Association Detection Project in Industry) . J Clin Epidemiol . 1989;42:257–267
  4. Reunanen A , Takkunen H , Knekt P , et al.   Hyperuricemia as a risk factor for cardiovascular mortality . Acta Med Scand . 1982;668:S49–S59
  5. Gillum RF , Mussolino ME , Madans JH . Fish consumption and hypertension incidence in African Americans and whites (The NHANES I epidemiologic follow-up study) . J Natl Med Assoc . 2001;93:124–128
  6. Paeratakul S , Lovejoy JC , Ryan DH , et al.   The relation of gender, race and socioeconomic status to obesity and obesity comorbidities in a sample of US adults . Int J Obes Relat Metab Disord . 2002;26:1205–1210
  7. Gillum RF , Mussolino ME , Madans JH . Coronary heart disease incidence and survival in African-American women and men. The NHANES I epidemiologic follow-up study . Ann Intern Med . 1997;127:111–118
  8. Alderman MH , Cohen H , Madhavan S , et al.   Serum uric acid and cardiovascular events in successfully treated hypertensive patients . Hypertension . 1999;34:144–150
  9. Stengel B , Tarver-Carr ME , Powe NR , et al.   Lifestyle factors, obesity and the risk of chronic kidney disease . Epidemiology . 2003;14:479–487
  10. Klag MJ , Whelton PK , Randall BL , et al.   End-stage renal disease in African-American and white men. 16-year MRFIT findings . JAMA . 1997;277:1293–1298
  11. Fang J , Alderman MH . Serum uric acid and cardiovascular mortality (The NHANES I epidemiologic follow-up study, 1971–1992) . JAMA . 2000;283:2404–2410
  12. Abbott RD , Brand FN , Kannel WB , et al.   Gout and coronary heart disease (The Framingham study) . J Clin Epidemiol . 1988;41:237–242
  13. Iribarren C , Sharp DS , Curb JD , et al.   High uric acid (A metabolic marker of coronary heart disease among alcohol abstainers?) . J Clin Epidemiol . 1996;49:673–678
  14. Franse VF , Pahor M , Di Bari M , et al.   Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP) . J Hypertens . 2000;18:1149–1154
  15. Bengtsson C , Lapidus L , Stendahl C , et al.   Hyperuricaemia and risk of cardiovascular disease and overall death . Acta Med Scand . 1988;224:549–555
  16. Nakanishi N , Tatara K , Nakamura K , et al.   Risk factors for the incidence of hyperuricaemia (A 6-year longitudinal study of middle-aged Japanese men) . Int J Epidemiol . 1999;28:888–893
  17. Choi HK , Atkinson K , Karlson EW , et al.   Purine-rich foods, dairy and protein intake, and the risk of gout in men . N Engl J Med . 2004;350:1093–1103
  18. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel, III). National Cholesterol Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) . Circulation . 2002;106:3143–3421
  19. Alberti KG , Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation . Diabet Med . 1998;15:539–553
  20. DeFronzo RA , Ferrannini E . Insulin resistance. A multifaceted syndrome responsible for NIDDM obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease . Diabetes Care . 1991;14:173–194
  21. Lakka HM , Laaksonen DE , Lakka TA , et al.   The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men . JAMA . 2002;288:2709–2716
  22. Sattar N , Gaw A , Scherbakova O , et al.   Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study . Circulation . 2003;108:414–419
  23. Chen J , Muntner P , Hamm L , et al.   The metabolic syndrome and chronic kidney disease in U.S. adults . Ann Intern Med . 2004;140:167–174
  24. Wannamethee SG , Shaper AG , Whincup PH . Serum urate and the risk of major coronary heart disease events . Heart . 1997;78:147–153
  25. Wannamethee SG . Is serum uric acid a risk factor for coronary heart disease . J Hum Hypertens . 1999;13:153–156
  26. Zavaroni I , Mazza S , Fantuzzi M , et al.   Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia . J Intern Med . 1993;234:25–30
  27. Staessen J  Members of the European Working Party on High Blood Pressure in the Elderly . The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly Trial . Am J Med . 1991;90:50S–54S
  28. Persky VW , Dyer AR , Idris-Soven E , et al.   Uric acid (A risk factor for coronary heart disease?) . Circulation . 1979;59:969–977
  29. Rathmann W , Hauner H , Dannehl K , et al.   Association of elevated serum uric acid with coronary heart disease in diabetes mellitus . Diabetes Metab . 1993;9:159–166
  30. Masuo K , Kawaguchi H , Mikami H , et al.   Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation . Hypertension . 2003;42:474–480
  31. Tuttle KR , Short RA , Johnson RJ . Sex differences in uric acid and risk factors for coronary artery disease . Am J Cardiol . 2001;87:1411–1414
  32. Short RA , Johnson RJ , Tuttle KR . Uric acid predicts cardiovascular disease in the absence of hypertension and independent of diuretic therapy, renal function, and microalbuminuria . J Am Soc Nephrol . 2003;14:676A
  33. Tuomilehto J , Zimmet P , Wolf E , et al.   Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji . Am J Epidemiol . 1988;127:321–336
  34. Weitzman S , Maislos M , Bodner-Fishman B , et al.   Association of diabetic retinopathy, ischemic heart disease, and albuminuria with diabetic treatment in type 2 diabetic patients . Acta Diabetol . 1997;34:275–279
  35. Leyva F , Anker S , Swan JW , et al.   Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure . Eur Heart J . 1997;18:858–865
  36. The Hypertension Detection and Follow-up Program Cooperative Research Group . Mortality findings for stepped-care and referred-care participants in the Hypertension Detection and Follow-up Program, stratified by other risk factors . Prev Med . 1985;14:312–335
  37. Johnson RJ , Kang DH , Feig D , et al.   Is there a pathogenic role for uric acid in hypertension, cardiovascular and renal disease? . Hypertension . 2003;41:1183–1190
  38. Brand FN , McGee DL , Kannel WB , et al.   Hyperuricemia as a risk factor of coronary heart disease (The Framingham study) . Am J Epidemiol . 1985;121:11–18
  39. Puig JG , Ruilope LM . Uric acid as a cardiovascular risk factor in arterial hypertension . J Hypertens . 1999;17:869–872
  40. Selby JV , Friedman GD , Quesenberry CP . Precursors of essential hypertension (Pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries) . Am J Epidemiol . 1990;131:1017–1027
  41. Jossa F , Farinaro E , Panico S , et al.   Serum uric acid and hypertension (The Olivetti heart study) . J Hum Hypertens . 1994;8:677–681
  42. Torres RJ , Martinez MA , Sancho T , et al.   Serum uric acid levels and microalbuminuria in mild hypertensive patients . Adv Exp Med Biol . 2000;486:135–137
  43. Feig DI , Johnson RJ . Hyperuricemia in childhood primary hypertension . Hypertension . 2003;42:247–252
  44. Bulpitt CJ , Beevers DG , Butlier A , et al.   The survival of treated hypertensive patients and their causes of death (A report from the DHSS Hypertensive Care Computing Project (DHCCP)) . J Hypertens . 1986;4:93–99
  45. Culleton BF , Larson MG , Kannel WB , et al.   Serum uric acid and risk for cardiovascular disease and death (The Framingham Heart Study) . Ann Intern Med . 1999;131:7–13
  46. Culleton BF . Uric acid and cardiovascular disease (A renal-cardiac relationship?) . Curr Opin Nephrol Hypertens . 2001;10:371–375
  47. Liese AD , Hense HW , Löwel H , et al.   Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg Cohort . Epidemiology . 1999;10:391–397
  48. Casiglia E , Spolaore P , Ginocchio G , et al.   Predictors of mortality in very old subjects aged 80 years or over . Eur J Epidemiol . 1993;9:577–586
  49. Wang JG , Staessen JA , Fagard RH , et al.   Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension . Hypertension . 2001;37:1069–1074
  50. Bickel C , Rupprecht HJ , Blankenberg S , et al.   Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease . Am J Cardiol . 2002;89:12–17
  51. Goldberg RJ , Burchfiel CM , Benfante R , et al.   Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men . Arch Intern Med . 1995;155:686–694
  52. Verdecchia P , Schillaci G , Reboldi G , et al.   Relation between serum uric acid and risk of cardiovascular disease in essential hypertension (The PIUMA Study) . Hypertension . 2000;36:1072–1078
  53. The Coronary Drug Project Research Group . Serum uric acid (Its association with other risk factors and with mortality in coronary heart disease) . J Chron Dis . 1976;29:557–569
  54. De Leeuw PW , Thijs L , Birkenhäger WH , et al.   Prognostic significance of renal function in elderly patients with isolated systolic hypertension (Results from the Syst-Eur Trial) . J Am Soc Nephrol . 2002;13:2213–2222
  55. Moriarity JT , Folsom AR , Iribarren C , et al.   Serum uric acid and risk of coronary heart disease (Atherosclerosis Risk in Communities (ARIC) Study) . Ann Epidemiol . 2003;10:136–143
  56. Johnson RJ , Tuttle KR . Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease . Hypertension . 2000;35:E10
  57. Kagan A , Gordon T , Rhoads GG , et al.   Some factors related to coronary heart disease incidence in Honolulu Japanese Men (The Honolulu Heart Study) . Int J Epidemiol . 1975;4:271–279
  58. Ward HJ . Uric acid as an independent risk factor in the treatment of hypertension . Lancet . 1998;352:670–671
  59. Nieto FJ , Iribarren C , Gross MD , et al.   Uric acid and serum antioxidant capacity (A reaction to atherosclerosis?) . Atherosclerosis . 2000;148:131–139
  60. Leyva F , Anker SD , Godsland IF , et al.   Uric acid in chronic heart failure (A marker of chronic inflammation) . Eur Heart J . 1998;19:1814–1822
  61. Anker SD , Doehner W , Rauchhaus M , et al.   Uric acid and survival in chronic heart failure (Validation and application in metabolic, functional, and hemodynamic staging) . Circulation . 2003;107:1991–1997
  62. Leyva F , Chua TP , Anker SD , et al.   Uric acid in chronic heart failure (A measure of the anaerobic threshold) . Metabolism . 1998;47:1156–1159
  63. Segura J , Campo C , Ruilope LM . How relevant and frequent is the presence of mild renal insufficiency in essential hypertension? . J Clin Hypertens . 2002;4:332–336
  64. Leoncini G , Viazzi F , Parodi D , et al.   Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension . Hypertension . 2003;42:14–18
  65. Iseki K , Oshiro S , Tozawa M , et al.   Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects . Hypertens Res . 2001;24:691–697
  66. Tomita M , Mizuno S , Yamanaka H , et al.   Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers . J Epidemiol . 2000;10:403–409
  67. Bigazzi R , Bianchi S , Baldari D , et al.   Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension . J Hypertens . 1998;16:1325–1333
  68. Ruilope LM , Garcia-Puig J . Hyperuricemia and renal function . Curr Hypertens Rep . 2001;3:197–202
  69. Geiger H , Bahner U , Heidland A . Does cadmium contribute to the development of renal parenchymal hypertension . Int J Artif Organs . 1989;12:733–737
  70. Geiger H , Bahner U , Anderes S , et al.   Cadmium and renal hypertension . J Hum Hypertens . 1989;3:23–27
  71. Miranda-Carus E , Mateos FA , Sanz AG , et al.   Purine metabolism in patients with gout (The role of lead) . Nephron . 1997;75:327–335
  72. Gerhardt U , Grosse HM , Hohage H . Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients . Clin Transplant . 1999;13:375–379
  73. Ohno I , Hosoya T , Gomi H , et al.   Serum uric acid and renal prognosis in patients with IgA nephropathy . Nephron . 2001;87:333–339
  74. Syrjanen J , Mustonen J , Pasternack A . Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy . Nephrol Dial Transplant . 2000;15:34–42
  75. Hunsicker LG , Adler S , Caggiula A , et al.   Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study . Kidney Int . 1997;51:1908–1919
  76. James LR , Mulaik SA , Brett JM . Causal Analysis (Assumptions, Models, and Data) . Beverly Hills, CA: Sage Publications, Inc; 1982;
  77. Joehlin JC . Latent Variable Models (An Introduction to Factor, Path, and Structural Analysis) . Hillsdale, NJ: Lawrence Erlbaum Associates; 1987;
  78. Hayduk LA . Structural Equation Modeling with LISREL (Essentials and Advances) . Baltimore: The Johns Hopkins University Press; 1987;
  79. Breckenridge A . Hypertension and hyperuricaemia . Lancet . 1966;1:15–18
  80. Johnson RJ , Kivlighn SD , Kim YG , et al.   Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease . Am J Kidney Dis . 1999;33:225–234

 Supported by The Heart Institute of Spokane and Sacred Heart Medical Center.

PII: S0270-9295(04)00148-2

doi: 10.1016/j.semnephrol.2004.09.005

Seminars in Nephrology
Volume 25, Issue 1 , Pages 25-31 , January 2005

Article Tools

* Image Usage & Resolution